NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
19 hedge funds and large institutions have $1.81M invested in InVivo Therapeutics Holdings Corp in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$162K | |
| 2 | +$85.5K | |
| 3 | +$66.4K | |
| 4 |
Morgan Stanley
New York
|
+$35.7K |
| 5 |
Goldman Sachs
New York
|
+$30K |
Top Sellers
| 1 | -$162K | |
| 2 | -$69.8K | |
| 3 | -$67K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59K |
| 5 |
Millennium Management
New York
|
-$28K |